glp-1 drugs contraindications Metabolic therapy is evolving faster than many clinics realize. In Episode 1 of Drug Decode, we break down: Afrezza® – needle-free prandial insulin Semaglutide – CV-proven therapy Tirzepatide – dual incretin GLP-1 Receptor Agonists - Pharmacology
Description
These include: Nausea Vomiting Diarrhoea Constipation Abdominal pain These side effects are typically mild to moderate, most common when starting the medication or increasing the dose, and often subside over time
More promising results, however, were announced the same month by Eli Lilly for its new once-daily GLP-1 pill which showed promise for weight management and for the treatment of type-2 diabetes
Other Ingredients: Gelatin, microcrystalline cellulose, silica, magnesium stearate
may be taken without food restrictions) achieve greater utilization
Only Wegovy and Saxenda have been approved for use as weight-loss medications by Health Canada
Patients with more advanced scarring may need closer monitoring, additional testing, and possibly specialist involvement
